Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proximal versus distal small-intestinal metformin administration in type 2 diabetes
ACTRN12617000243314Phase 2Completed
- Sponsor
- University of Adelaide
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by University of Adelaide. Primary endpoints: Incremental area under the curve for plasma glucose, Incremental area under the curve for plasma GLP-1 and 1 more. Started Apr 2017; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12617000243314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000243314.